8Mon·
8
14 Comments

profile image
Buy the dip
15
Yes, the share feels like riding a rollercoaster in an amusement park ;)

But fundamentally, I think it looks very good here.
6
profile image
@Marvin_Kapital would now be a good entry opportunity? I haven't invested yet
@Max095 This cannot be said across the board, as the price could well fall towards 15 dollars due to speculators. Hims will remain very volatile as long as the weight loss issue is in focus.
I am very bullish in the long term due to strong growth and a very good balance sheet. But I could also be wrong.
6
profile image
@Max095 I think it's a good opportunity to get in. Earnings are on Monday, so it can quickly go in the other direction and be "too late" again. And the more the share falls now, the more likely it is that this will also happen on Monday
2
profile image
Comment was deleted
profile image
@Max095 proceeding in tranches is never wrong with volatile values 👍
3
profile image
Focus more on the company and the figures than on the share. We will stay calm until Monday and buy the dip.
6
profile image
Eli Lilly has disappointed with the sales of GLP-1. This is probably the reason for the drop at Hims.
6
profile image
@AdriInvests yep, I haven't found any other message so far that could be responsible for this. As if HIMS only consisted of GLPs. It's getting on my nerves. Why are they all so nervous holy shit.
6
profile image
@DerAzubi Thank you for the news. It's as if it happened so quickly after all. I don't really trust the whole thing yet. We'll have to wait and see. What Dudum will say in the earnings call on Monday will be all the more exciting. The investors will pester him with questions about the GLPs haha
profile image
it's like this every time there's news about glp-1
profile image
Time to buy again
Join the conversation